BIO-Europe 2024

June 21, 2024/in Event/by chi9iua

Going Global - Chime Biologics Embraces Innovation and Quality with Partners

June 18, 2024/in Corporate News, News/by chi9iua

CHO Cell Line Development: Process and Key Technical Points Overview

June 6, 2024/in NewsRoom, Science & Technology/by chi9iua

CHO Cell Line Development: Process and Key Technical Points Overview No content available

2024 China Biologics Going Global Forum

June 5, 2024/in Event/by chi9iua

(中文) 生物类似药中美欧法规速递

May 23, 2024/in Corporate News, NewsRoom, Science & Technology/by chi9iua

Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

BIO International Convention 2024

May 23, 2024/in Event/by chi9iua

Whitepaper | Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies

April 19, 2024/in Corporate News, Uncategorized, Whitepapers/by chi9iua

Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy

March 12, 2024/1 Comment/in Corporate News, News/by Qiqi Zhang

Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

March 7, 2024/in News/by Qiqi Zhang

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

September 28, 2023/1 Comment/in Corporate News, News/by Qiqi Zhang

BIO-Europe 2024

Going Global - Chime Biologics Embraces Innovation and Quality with Partners

CHO Cell Line Development: Process and Key Technical Points Overview

2024 China Biologics Going Global Forum

(中文) 生物类似药中美欧法规速递

BIO International Convention 2024

Whitepaper | Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies

Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy

Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

ABOUT US

Our Services

CONTACT US